{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:41:36Z","timestamp":1760121696411},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thoracic Surgery Clinics"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.thorsurg.2008.07.003","type":"journal-article","created":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T08:16:23Z","timestamp":1225181783000},"page":"393-401","source":"Crossref","is-referenced-by-count":6,"title":["Definitive Chemoradiotherapy for Non\u2013Small Cell Lung Cancer with N2 Disease"],"prefix":"10.1016","volume":"18","author":[{"given":"Shilpen","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel E.","family":"Sanborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Charles R.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thorsurg.2008.07.003_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-5002(98)00046-4","article-title":"Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer","volume":"21","author":"Roth","year":"1998","journal-title":"Lung Cancer"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib3","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/1097-0142(19870601)59:11<1874::AID-CNCR2820591106>3.0.CO;2-Z","article-title":"Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group","volume":"59","author":"Perez","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group","volume":"311","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.7326\/0003-4819-125-9-199611010-00003","article-title":"Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis","volume":"125","author":"Pritchard","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/1097-0142(19950815)76:4<593::AID-CNCR2820760409>3.0.CO;2-N","article-title":"Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis","volume":"76","author":"Marino","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib7","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jnci\/88.17.1210","article-title":"Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial","volume":"88","author":"Dillman","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJM199010043231403","article-title":"A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer","volume":"323","author":"Dillman","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1378\/chest.117.2.358","article-title":"Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group","volume":"117","author":"Sause","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.7326\/0003-4819-115-9-681","article-title":"Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial","volume":"115","author":"Morton","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199202203260805","article-title":"Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer","volume":"326","author":"Schaake-Koning","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0360-3016(92)91079-3","article-title":"Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer","volume":"24","author":"Trovo","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib13","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1200\/JCO.1995.13.6.1425","article-title":"Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol","volume":"13","author":"Blanke","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib14","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer","volume":"17","author":"Furuse","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib15","first-page":"484a","article-title":"Phase III comparison of sequential versus concurrent chemoradiation for patients with unresected stage III non small cell lung cancer: initial report of RTOG 9410","volume":"19","author":"Curran","year":"2000","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib16","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1200\/JCO.2002.03.054","article-title":"Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431","volume":"20","author":"Vokes","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3816\/CLC.2005.n.021","article-title":"Induction paclitaxel\/carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study\u2013CALGB 9534","volume":"7","author":"Akerley","year":"2005","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib18","doi-asserted-by":"crossref","first-page":"7528","DOI":"10.1200\/jco.2007.25.18_suppl.7528","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy (CCRT) versus CCRT alone for unresectable stage III non-small cell lung cancer: randomized phase III trial","volume":"25","author":"Kim","year":"2007","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib19","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1200\/JCO.2006.07.3569","article-title":"Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: Cancer and Leukemia Group B","volume":"25","author":"Vokes","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib20","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1200\/JCO.2002.03.055","article-title":"Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019","volume":"20","author":"Albain","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib21","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1200\/JCO.2003.04.197","article-title":"Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504","volume":"21","author":"Gandara","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3816\/CLC.2006.n.039","article-title":"Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group study (S9504)","volume":"8","author":"Gandara","year":"2006","journal-title":"Clin Lung Cancer"},{"issue":"15","key":"10.1016\/j.thorsurg.2008.07.003_bib23","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1200\/JCO.2007.14.4824","article-title":"Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023","volume":"26","author":"Kelly","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib24","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1200\/JCO.2005.55.405","article-title":"Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol","volume":"23","author":"Belani","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib25","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1200\/jco.2007.25.18_suppl.7512","article-title":"Phase III trial of cisplatin plus etoposide plus concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small cell lung cancer: HOG LUN 01-24\/USO-023","volume":"25","author":"Hanna","year":"2007","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/JTO.0b013e3181622c17","article-title":"Prevalence of poor performance status in lung cancer patients: implications for research","volume":"3","author":"Lilenbaum","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib27","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1200\/JCO.1998.16.9.3078","article-title":"Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer","volume":"16","author":"Lau","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib28","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1200\/JCO.2006.07.0268","article-title":"Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712","volume":"24","author":"Davies","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib29","unstructured":"National Cancer Institute. Available at: www.cancer.gov. Accessed September 2008."},{"key":"10.1016\/j.thorsurg.2008.07.003_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1259\/0007-1285-46-541-1","article-title":"Clinical dose response curves of human malignant epithelial tumours","volume":"46","author":"Fletcher","year":"1973","journal-title":"Br J Radiol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib31","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/1097-0142(20010901)92:5<1213::AID-CNCR1440>3.0.CO;2-0","article-title":"Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin\/paclitaxel in unresectable stage IIIA\/B nonsmall cell lung carcinoma: a modified phase I\/II trial","volume":"92","author":"Socinski","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib32","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijrobp.2004.06.260","article-title":"Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma","volume":"61","author":"Bradley","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib33","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ijrobp.2005.01.003","article-title":"The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer","volume":"62","author":"Schild","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/01243894-200606000-00010","article-title":"Phase Ia\/Ib chemo-radiation trial of gemcitabine and dose-escalated thoracic radiation in patients with stage III A\/B non-small cell lung cancer","volume":"1","author":"Blackstock","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib35","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1200\/jco.2006.24.18_suppl.7042","article-title":"Induction plus concurrent chemotherapy with high-dose (74 Gy) 3-dimensional thoracic radiotherapy in stage III non-small cell lung cancer: preliminary report of Cancer and Leukemia Group B (CALGB) 30105","volume":"24","author":"Blackstock","year":"2006","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib36","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1200\/JCO.2004.08.163","article-title":"Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy","volume":"22","author":"Hanna","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib37","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1200\/jco.2007.25.18_suppl.18032","article-title":"Safety study of induction chemotherapy and synchronous radiotherapy and cetuximab in stage III non-small cell lung cancer: SCRATCH (Cohort 1)","volume":"25","author":"Hughes","year":"2007","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib38","first-page":"2286","article-title":"Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer","volume":"8","author":"Lord","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib39","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib40","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1200\/JCO.2006.06.1101","article-title":"RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer","volume":"24","author":"Bepler","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib41","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1200\/jco.2007.25.18_suppl.7502","article-title":"Molecular analysis-directed individualized therapy (MADeIT) in advanced non-small cell lung cancer","volume":"25","author":"Simon","year":"2007","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib42","doi-asserted-by":"crossref","first-page":"7510","DOI":"10.1200\/jco.2008.26.15_suppl.7510","article-title":"A 15-gene expression signature prognostic for survival and predictive for adjuvant chemotherapy benefit in JBR.10 patients","volume":"26","author":"Tsao","year":"2008","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib43","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1200\/jco.2008.26.15_suppl.7532","article-title":"Validation of 5- and 3-gene expression signatures for predicting outcome in non-small cell lung cancer patients","volume":"26","author":"Skrzypski","year":"2008","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.thorsurg.2008.07.003_bib44","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1200\/jco.2008.26.15_suppl.7511","article-title":"Use of co-activation of lung cancer specific developmental pathway genes, TTF-1, NKX2-8, and PAX9, to predict prognosis and guide therapeutic strategies","volume":"26","author":"Hsu","year":"2008","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Thoracic Surgery Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412708000686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412708000686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:01:41Z","timestamp":1589040101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547412708000686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S1547412708000686"],"URL":"https:\/\/doi.org\/10.1016\/j.thorsurg.2008.07.003","relation":{},"ISSN":["1547-4127"],"issn-type":[{"value":"1547-4127","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}